Cargando…
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of bi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451735/ https://www.ncbi.nlm.nih.gov/pubmed/32875127 http://dx.doi.org/10.1016/j.ctro.2020.08.002 |
_version_ | 1783575039081185280 |
---|---|
author | Gomez-Iturriaga, A. Büchser, D. Miguel, I. San Marban, M. Urresola, A. Ezquerro, A. Gil, A. Suarez, F. Gonzalez, A. Mairata, E. Martinez-Indart, L. Cacicedo, J. Couñago, F. Mínguez, P. Casquero, F. |
author_facet | Gomez-Iturriaga, A. Büchser, D. Miguel, I. San Marban, M. Urresola, A. Ezquerro, A. Gil, A. Suarez, F. Gonzalez, A. Mairata, E. Martinez-Indart, L. Cacicedo, J. Couñago, F. Mínguez, P. Casquero, F. |
author_sort | Gomez-Iturriaga, A. |
collection | PubMed |
description | MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases. |
format | Online Article Text |
id | pubmed-7451735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74517352020-08-31 MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? Gomez-Iturriaga, A. Büchser, D. Miguel, I. San Marban, M. Urresola, A. Ezquerro, A. Gil, A. Suarez, F. Gonzalez, A. Mairata, E. Martinez-Indart, L. Cacicedo, J. Couñago, F. Mínguez, P. Casquero, F. Clin Transl Radiat Oncol Article MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases. Elsevier 2020-08-13 /pmc/articles/PMC7451735/ /pubmed/32875127 http://dx.doi.org/10.1016/j.ctro.2020.08.002 Text en © 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Gomez-Iturriaga, A. Büchser, D. Miguel, I. San Marban, M. Urresola, A. Ezquerro, A. Gil, A. Suarez, F. Gonzalez, A. Mairata, E. Martinez-Indart, L. Cacicedo, J. Couñago, F. Mínguez, P. Casquero, F. MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
title | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
title_full | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
title_fullStr | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
title_full_unstemmed | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
title_short | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
title_sort | mri detected extaprostatic extension (epe) in prostate cancer: do all t3a patients have the same outcomes? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451735/ https://www.ncbi.nlm.nih.gov/pubmed/32875127 http://dx.doi.org/10.1016/j.ctro.2020.08.002 |
work_keys_str_mv | AT gomeziturriagaa mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT buchserd mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT miguelisan mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT marbanm mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT urresolaa mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT ezquerroa mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT gila mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT suarezf mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT gonzaleza mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT mairatae mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT martinezindartl mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT cacicedoj mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT counagof mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT minguezp mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT casquerof mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes |